Cytology, liquid-based cytology and automation

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Cytology-based screening significantly reduces cervical cancer incidence and mortality.
• Management of low-grade squamous abnormalities in cervical cytology was previously uncertain.
• Liquid-based cytology (LBC) has enhanced specimen quality and enabled human papillomavirus (HPV) testing.

Purpose of the Study:

• To review the advancements in cervical cancer screening, particularly with liquid-based cytology.
• To evaluate the role of HPV testing in managing low-grade cervical abnormalities.
• To assess the efficacy and limitations of automation-assisted reading in cervical cytology.

Main Methods:

• Review of quality-assured, comprehensive cytology-based population screening programs.
• Analysis of liquid-based cytology's impact on specimen adequacy and HPV testing integration.
• Evaluation of recent studies on automation-assisted reading versus manual reading of cervical cytology samples.

Main Results:

• LBC has improved specimen adequacy and laboratory efficiency, facilitating HPV testing for triage and follow-up.
• HPV testing via LBC is crucial for managing low-grade abnormalities and for primary screening in HPV-vaccinated populations.
• Recent studies indicate automation-assisted reading is less sensitive than manual reading and does not decrease cervical cancer risk.

Conclusions:

• Cytology-based screening remains effective in reducing cervical cancer burden.
• Liquid-based cytology offers significant advantages for HPV testing and improved screening strategies.
• Automation-assisted reading in cervical cytology requires further validation due to reported lower sensitivity compared to manual methods.